February 2009 Volume 43 Number 3, pp 181 - 264
---------------------------------------------------------------------
Lymphocytes Return Home
Immunology & Cell Biology is proud to bring you Lymphocytes Return
Home - a focus that brings together a collection of articles
representingour current understanding of how numerous cell types
can return to the thymus. Accompanying this focus is a special
feature dealing with the nature and possible functional consequences
of cellular traffic, both lymphoid and myeloid, back to the primary
lymphoid organs.
Take advantage of this limited time offer today!
Lymphocytes Return Home
http://links.ealert.nature.com/ctt?kn=64&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://links.ealert.nature.com/ctt?kn=57&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
to start your subscription today.
----------------------
REVIEW
----------------------
Improving stem cell mobilization strategies: future directions
W Bensinger, J F DiPersio and J M McCarty
Abstract: http://links.ealert.nature.com/ctt?kn=68&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=71&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
EPO in combination with G-CSF improves mobilization effectiveness after
chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs
during mobilization and transplantation of autologous hematopoietic progenitor cells
C Hart, J Grassinger, R Andreesen and B Hennemann
Abstract: http://links.ealert.nature.com/ctt?kn=56&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=7&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Outcome following unrelated cord blood transplant in 136 patients with
malignant and non-malignant diseases: a report from the Australian and
New Zealand children's haematology and oncology group
T E Petterson, M Gabriel, K Tiedemann, L Teague, P J Shaw, D Baker, R
Bolton-Jones, H Tapp, C Oswald, M R Vowels and T A O'Brien
Abstract: http://links.ealert.nature.com/ctt?kn=38&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=15&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Challenges in the use of allogeneic hematopoietic SCT for ectodermal
dysplasia with immune deficiency
J D Fish, R E Duerst, E W Gelfand, J S Orange and N Bunin
Abstract: http://links.ealert.nature.com/ctt?kn=5&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=27&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Contaminating tumour cells in autologous PBSC grafts do not influence
survival or relapse following transplant for multiple myeloma or B-cell
non-Hodgkin's lymphoma
J Ho, L Yang, B Banihashemi, L Martin, M Halpenny, H Atkins, M Sabloff,
S A McDiarmid, L B Huebsch, I Bence-Bruckler, A Giulivi and D S Allan
Abstract: http://links.ealert.nature.com/ctt?kn=13&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=3&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Little impact of donor/recipient major mismatch for neutrophil-specific
antigen NA2 on neutrophil recovery after allogeneic SCT
T Inukai, K Goi, T Tezuka, K Uno, A Nemoto, K Takahashi, H Sato, K Akahane,
K Hirose, H Honna, I Kuroda, K Kagami, K Nakamoto, K Taniguchi, S Nakazawa
and K Sugita
Abstract: http://links.ealert.nature.com/ctt?kn=40&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=62&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Fewer infections and lower infection-related mortality following non-myeloablative
versus myeloablative conditioning for allotransplantation of patients with lymphoma
V Bachanova, C G Brunstein, L J Burns, J S Miller, X Luo, T Defor, J-Ah Young, D J
Weisdorf and M Tomblyn
Abstract: http://links.ealert.nature.com/ctt?kn=53&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=45&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Treatment of refractory acute GVHD with third-party MSC expanded in platelet
lysate-containing medium
M von Bonin, F Stolzel, A Goedecke, K Richter, N Wuschek, K Holig, U Platzbecker,
T Illmer, M Schaich, J Schetelig, A Kiani, R Ordemann, G Ehninger, M Schmitz and
M Bornhauser
Abstract: http://links.ealert.nature.com/ctt?kn=25&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=66&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib
(Velcade)
M Arpinati, G Chirumbolo, B Nicolini, C Agostinelli and D Rondelli
Abstract: http://links.ealert.nature.com/ctt?kn=52&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=33&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
----------------------
LETTERS TO THE EDITOR
----------------------
Should busulfan-containing regimen be avoided for young female patients
undergoing hematopoietic stem cell transplantation?
S Okuda, M Sato, K Terasako, S Kako, K Oshima and Y Kanda
http://links.ealert.nature.com/ctt?kn=63&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
G-CSF-induced thrombocytopenia in a healthy donor
O Minelli, F Falzetti, M Di Ianni, M Onorato, S Plebani, C Silvani and A
Tabilio
http://links.ealert.nature.com/ctt?kn=72&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
--------------------------------------------------------------------
Cool new website, Hot science jobs!
Naturejobs is pleased to announce naturejobs.com has a new and
improved look and functionality making your online experience even
better!
Check out our redesign and find thousands of scientific vacancies,
careers information, podcasts, advertising options and more!
http://links.ealert.nature.com/ctt?kn=67&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=26&m=31354031&r=MTc1NjE0NTQ4OQS2&b=2&j=NDU3MDI4NzES1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
